Found: 13
Select item for more details and to access through your institution.
Smartphone Photographs of Chronic Urticaria Taken by Patients Are of Good Quality and Useful in the Clinic.
- Published in:
- Dermatology (10188665), 2024, v. 240, n. 3, p. 357, doi. 10.1159/000535027
- By:
- Publication type:
- Article
Events during the 3 Months Immediately Preceding Onset of Chronic Urticaria: A Questionnaire Study.
- Published in:
- Dermatology (10188665), 2021, v. 237, n. 2, p. 320, doi. 10.1159/000505514
- By:
- Publication type:
- Article
Factors affecting quality of life in patients with hidradenitis suppurativa.
- Published in:
- Archives of Dermatological Research, 2020, v. 312, n. 6, p. 427, doi. 10.1007/s00403-019-02025-5
- By:
- Publication type:
- Article
Prevalence and predictors of hypothyroidism in patients with chronic spontaneous urticaria.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 9, p. 1588, doi. 10.1111/exd.14832
- By:
- Publication type:
- Article
Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Biological treatment of palmoplantar pustulosis: Long‐term experience in 10 patients.
- Published in:
- Dermatologic Therapy, 2021, v. 34, n. 2, p. 1, doi. 10.1111/dth.14780
- By:
- Publication type:
- Article
Omalizumab for cholinergic urticaria: 6 months prospective study and systematic review of the literature.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 6, p. 1, doi. 10.1111/dth.14010
- By:
- Publication type:
- Article
Fluctuations in serum levels of adalimumab and infliximab in patients on stable treatment for psoriasis.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 4, p. 1, doi. 10.1111/dth.13497
- By:
- Publication type:
- Article
Positive basophil histamine release assay predicts insufficient response to standard‐dosed omalizumab in patients with chronic spontaneous urticaria.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 12, p. 1318, doi. 10.1111/cea.14402
- By:
- Publication type:
- Article
Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study.
- Published in:
- Clinical & Experimental Allergy, 2022, v. 52, n. 5, p. 715, doi. 10.1111/cea.14121
- By:
- Publication type:
- Article
Plasma proteomics analysis of patients with chronic spontaneous urticaria reveals significant associations with key disease characteristics but not with response to omalizumab treatment.
- Published in:
- Allergy, 2024, v. 79, n. 9, p. 2547, doi. 10.1111/all.16175
- By:
- Publication type:
- Article
Clinical applicability of the urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes.
- Published in:
- Allergy, 2024, v. 79, n. 1, p. 263, doi. 10.1111/all.15955
- By:
- Publication type:
- Article
Biomarkers for Monitoring Treatment Response of Omalizumab in Patients with Chronic Urticaria.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11328, doi. 10.3390/ijms241411328
- By:
- Publication type:
- Article